(Originally published in Guyana’s Stabroek News on 05 November 2011)
When I found out that my eldest daughter was diagnosed with the human
papillomavirus (HPV), I was more than a bit distressed. Cancer runs in
my family and, in fact, my mother died of a different form of cancer at
the young age of 48. Therefore, it was a frightening thing to discover
my 24-year-old daughter had a virus that is known to cause cervical
cancer.
According to an October 14 report by the Centers for
Disease Control (CDC), “Cervical cancer is a major cause of morbidity
and mortality in the Americas, where an estimated 80,574
new cases and 36,058 deaths were reported in 2008, with 85% of this
burden occurring in Latin America and the Caribbean. Two oncogenic human
papillomavirus types (16 and 18) cause approximately 70% of cervical
cancers and a substantial proportion of other HPV-related cancers.”
Concerning Guyana, a report by the Remote Area Medical [RAM] Guyana
Cervical Cancer Project said, “According to the Pan American Health
Organisation, in 2002 the incidence of cervical cancer in Guyana was
47.3 per 100,000, and the mortality rate 22.2 per 100,000. By contrast,
the incidence and mortality in the US were 7 and 2.3 per 100,000
respectively.”
The good news is that in 2009 a vaccine was made
available to prevent disease caused by the oncogenic subtypes 16 and 18,
said to be responsible for approximately 70% of all cervical cancers
worldwide. Two years on, it still boggles my mind that humans have
created a vaccine against cancer.
The CDC suggests that, “Because
HPV infections are acquired soon after initiation of sexual activity,
HPV vaccine is most effective if administered before onset of sexual
activity. The World Health Organisation (WHO) recommends a 3-dose
vaccine schedule, completed over the course of 6 months, for a likely
primary target population of girls within the age range of 9 or 10 years
through 13 years.”
In other words, diligence is necessary to make
sure the patient receives all three doses, but the solace that comes
with knowing the effectiveness of this vaccine is worth the effort. What
can be even better than knowing a vaccine to prevent cervical cancer
exists for our daughters? Knowing that Guyana now has this vaccine!
A
Kaieteur News report from October 30 entitled, ‘HPV vaccines arrive in
Guyana’, said, “Within a matter of two weeks 20,000 doses of the Human
Papilloma Virus (HPV) will be administered to girls as young as 11 years
old, as part of the Ministry of Health’s attempt to protect them
against cervical cancer.”
I am very excited about this news, as I
do not want other mothers to have to experience the feelings of fear I
felt when I discovered my daughter was diagnosed with HPV. I know there
are some who are wary of vaccines. I understand this completely, which
is why it is important for each parent to do their own research to weigh
the risks that come with HPV and the probability of your daughter
contracting HPV if she does not get vaccinated against any possible side
effects that may accompany the vaccine.
How safe is the HPV
vaccine? According to the CDC, “The [Food and Drug Administration] FDA
has licensed the vaccines as safe and effective. Both vaccines were
tested in thousands of people around the world. These studies showed no
serious safety concerns. Common, mild adverse events reported during
these studies include pain where the shot was given, fever, dizziness,
and nausea. As with all vaccines, CDC and FDA continue to monitor the
safety of these vaccines very carefully.”
The CDC also stated that
the vaccine is highly effective in preventing specific HPV types and
the most common health problems from HPV. From my own brief research,
there seems to have been some mild side effects from the vaccine in some
recipients, but there does not appear to be any serious side effects
proven to be linked to it. However, like I said, parents should do their
own research.
Additionally, there has been an ongoing debate in
the US over a moral dilemma concerning this vaccine. Since HPV is
usually transmitted during sexual activity, there are some who maintain
that by getting their daughters vaccinated against HPV, they are
encouraging them to have sex.
This would be like saying if I put a
raincoat on today, I will cause it to rain. It would seem a wiser
notion to get your daughter vaccinated on the chance that she may become
sexually active during her teen years (as many teenagers do) rather
than to refuse to vaccinate her on this moral ground and leave her
vulnerable to HPV and cervical cancer.
I have seen the devastating effects of cancer and I choose to protect my youngest daughter from any such outcome.
It
takes much time and effort to get leaders to take women’s issues
seriously – and this includes female health issues. I am very pleased to
see this very important step toward maintaining the health of the women
of Guyana.
The Kaieteur News report states that 20,000 HPV
vaccine doses were received. However, this vaccine must be administered
three times in a six-month period. As such, I hope the subsequent
vaccines necessary to make this treatment effective are already on their
way and not held up by the famous red tape that encumbers Guyana all
too often.
The newest information on the HPV vaccine is that it
can also be administered to boys. On October 25, the Advisory Committee
on Immunization Practices of CDC made the vaccination recommendation
for males 13 to 21 years who have not been vaccinated previously or who
have not completed the three-dose series.
This is another
remarkable development since both men and women can be carriers of HPV.
The fight against cancer, in all its forms, has been a long and arduous
one. That we have this one victory that can save the lives of thousands
of women and promote healthy lives for millions more, gives hope that
one day we can demolish cancer altogether.
No comments:
Post a Comment
Thank you for your comment. It is in the moderation process now and will be posted once it is approved.